Copyright
©The Author(s) 2020.
World J Gastrointest Pharmacol Ther. Nov 8, 2020; 11(5): 110-122
Published online Nov 8, 2020. doi: 10.4292/wjgpt.v11.i5.110
Published online Nov 8, 2020. doi: 10.4292/wjgpt.v11.i5.110
Table 2 Postoperative recurrence after the initial liver resection and additional surgery
| Postoperative recurrence after the initial LR and additional surgery | n |
| The target sites at the first recurrences after the initial LR (n = 21) | |
| Liver | 8 |
| LNs | 5 |
| Liver and LNs | 3 |
| Lung | 2 |
| Liver and lung | 2 |
| Liver, LNs and peritoneum | 1 |
| Peritoneum | 1 |
| Additional surgeries for postoperative recurrences after the initial LR (n = 9) | |
| LR | 3 |
| LN dissection | 2 |
| Lung resection | 2 |
| LR and LN dissection | 1 |
| LR and lung resection | 1 |
- Citation: Yazawa T, Hori T, Yamamoto H, Harada H, Yamamoto M, Yamada M, Tani M, Sato A, Kamada Y, Tani R, Aoyama R, Sasaki Y, Zaima M. Do liver metastases from gastric cancer contraindicate aggressive surgical resection? A 14-year single-center experience. World J Gastrointest Pharmacol Ther 2020; 11(5): 110-122
- URL: https://www.wjgnet.com/2150-5349/full/v11/i5/110.htm
- DOI: https://dx.doi.org/10.4292/wjgpt.v11.i5.110